Narcolepsy following COVID‐19: A case report and review of potential mechanisms


Yazdani Roya, 1 Barzkar Farzaneh, 2 Almasi‐Dooghaee Mostafa, 1 Shojaie Mahsa, 1 and Zamani Babak 1 Clin Case Rep. 2023 Jun; 11(6): e7370. Published online 2023 May 25.https://doi.org/10.1002/ccr3.7370, PMCID: PMC10213711, PMID: 37251741 Abstract Key Clinical Message The immune activation in COVID‐19 may trigger narcolepsy in vulnerable patients. We suggest clinicians carefully evaluate patients with post‐COVID fatigue and hypersomnia for primary sleep disorders, specifically narcolepsy. Abstract The patient […]

Narcolepsy following COVID‐19: A case report and review of potential mechanisms


Yazdani Roya, 1 Barzkar Farzaneh, 2 Almasi‐Dooghaee Mostafa, 1 Shojaie Mahsa, 1 and Zamani Babak 1 Clin Case Rep. 2023 Jun; 11(6): e7370. Published online 2023 May 25. doi: 10.1002/ccr3.7370 PMCID: PMC10213711, PMID: 37251741 Key Clinical Message The immune activation in COVID‐19 may trigger narcolepsy in vulnerable patients. We suggest clinicians carefully evaluate patients with post‐COVID fatigue and hypersomnia for primary sleep disorders, specifically narcolepsy. Abstract The patient is a […]

Treatment with stimulants and the risk of COVID-19 complications in adults with ADHD


Wen-Jan Tuan,a,⁎ Dara E. Babinski,b David P. Rabago,a,b,c and Aleksandra E. Zgierskac Abstract Adults with attention deficit hyperactivity disorder (ADHD) have shown higher infection rates and worse outcomes from COVID-19. Stimulant medications are prescribed as the first-line treatment for ADHD in adults and mitigate risk of negative ADHD-related health outcomes, but little is known about the association between stimulant […]